Eradication of Pulmonary Aspergillosis in an Adolescent Patient Undergoing Three Allogeneic Stem Cell Transplantations for Acute Lymphoblastic Leukemia

Systemic fungal infections are a major cause of infection-related mortality in patients with hematologic malignancies. This report addresses the case of an adolescent patient with acute lymphoblastic leukemia who underwent three allogeneic hematopoietic stem cell transplantations and developed pulmo...

Full description

Saved in:
Bibliographic Details
Main Authors: Michaela Döring, Angelika Zierl, Markus Mezger, Peter Lang, Rupert Handgretinger, Ingo Müller
Format: Article
Language:English
Published: Wiley 2012-01-01
Series:Case Reports in Transplantation
Online Access:http://dx.doi.org/10.1155/2012/672923
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849409259559714816
author Michaela Döring
Angelika Zierl
Markus Mezger
Peter Lang
Rupert Handgretinger
Ingo Müller
author_facet Michaela Döring
Angelika Zierl
Markus Mezger
Peter Lang
Rupert Handgretinger
Ingo Müller
author_sort Michaela Döring
collection DOAJ
description Systemic fungal infections are a major cause of infection-related mortality in patients with hematologic malignancies. This report addresses the case of an adolescent patient with acute lymphoblastic leukemia who underwent three allogeneic hematopoietic stem cell transplantations and developed pulmonary aspergillosis. Combination therapy with liposomal amphotericin B (L-AmB, 3 mg/kg bw/day) and caspofungin (CAS, 50 mg/day) during the first allogeneic hematopoietic stem cell transplantation (HSCT) improved the pulmonary situation. After shifting the antifungal combination therapy to oral voriconazole (2 × 200 mg/day) and CAS, a new pulmonal lesion occurred alongside the improvements in the existing pulmonary aspergillosis. An antifungal combination during a second HSCT with L-AmB (3 mg/kg bw/day) and CAS showed an improvement in the pulmonary aspergillosis. A combination therapy with CAS and L-AmB (1 mg/kg bw/day) during the third HSCT led once again to progress the pulmonary aspergillosis, after increasing the L-AMB to 3 mg/kg bw/day for recovery. The presented case provides an example of how, despite severe immunosuppression, a combination of antifungal drugs administered intravenously at therapeutic dosages may be more efficient than either intravenous monotherapy or combinations of intravenous and oral antifungals in selecting pediatric and adolescent patients with proven fungal infections.
format Article
id doaj-art-7e3eaf6491c243568942469c2ef15d80
institution Kabale University
issn 2090-6943
2090-6951
language English
publishDate 2012-01-01
publisher Wiley
record_format Article
series Case Reports in Transplantation
spelling doaj-art-7e3eaf6491c243568942469c2ef15d802025-08-20T03:35:33ZengWileyCase Reports in Transplantation2090-69432090-69512012-01-01201210.1155/2012/672923672923Eradication of Pulmonary Aspergillosis in an Adolescent Patient Undergoing Three Allogeneic Stem Cell Transplantations for Acute Lymphoblastic LeukemiaMichaela Döring0Angelika Zierl1Markus Mezger2Peter Lang3Rupert Handgretinger4Ingo Müller5Department of Pediatric Hematology/Oncology, University Children’s Hospital Tübingen, Hoppe-Seyler-Strß 1, 72076 Tübingen, GermanyDepartment of Pediatric Diagnostic Radiology, Olga-Hospital Stuttgart, Bismarckstraß 8, 70176 Stuttgart, GermanyDepartment of Pediatric Hematology/Oncology, University Children’s Hospital Tübingen, Hoppe-Seyler-Strß 1, 72076 Tübingen, GermanyDepartment of Pediatric Hematology/Oncology, University Children’s Hospital Tübingen, Hoppe-Seyler-Strß 1, 72076 Tübingen, GermanyDepartment of Pediatric Hematology/Oncology, University Children’s Hospital Tübingen, Hoppe-Seyler-Strß 1, 72076 Tübingen, GermanyDepartment of Pediatric Hematology/Oncology, University Children’s Hospital Tübingen, Hoppe-Seyler-Strß 1, 72076 Tübingen, GermanySystemic fungal infections are a major cause of infection-related mortality in patients with hematologic malignancies. This report addresses the case of an adolescent patient with acute lymphoblastic leukemia who underwent three allogeneic hematopoietic stem cell transplantations and developed pulmonary aspergillosis. Combination therapy with liposomal amphotericin B (L-AmB, 3 mg/kg bw/day) and caspofungin (CAS, 50 mg/day) during the first allogeneic hematopoietic stem cell transplantation (HSCT) improved the pulmonary situation. After shifting the antifungal combination therapy to oral voriconazole (2 × 200 mg/day) and CAS, a new pulmonal lesion occurred alongside the improvements in the existing pulmonary aspergillosis. An antifungal combination during a second HSCT with L-AmB (3 mg/kg bw/day) and CAS showed an improvement in the pulmonary aspergillosis. A combination therapy with CAS and L-AmB (1 mg/kg bw/day) during the third HSCT led once again to progress the pulmonary aspergillosis, after increasing the L-AMB to 3 mg/kg bw/day for recovery. The presented case provides an example of how, despite severe immunosuppression, a combination of antifungal drugs administered intravenously at therapeutic dosages may be more efficient than either intravenous monotherapy or combinations of intravenous and oral antifungals in selecting pediatric and adolescent patients with proven fungal infections.http://dx.doi.org/10.1155/2012/672923
spellingShingle Michaela Döring
Angelika Zierl
Markus Mezger
Peter Lang
Rupert Handgretinger
Ingo Müller
Eradication of Pulmonary Aspergillosis in an Adolescent Patient Undergoing Three Allogeneic Stem Cell Transplantations for Acute Lymphoblastic Leukemia
Case Reports in Transplantation
title Eradication of Pulmonary Aspergillosis in an Adolescent Patient Undergoing Three Allogeneic Stem Cell Transplantations for Acute Lymphoblastic Leukemia
title_full Eradication of Pulmonary Aspergillosis in an Adolescent Patient Undergoing Three Allogeneic Stem Cell Transplantations for Acute Lymphoblastic Leukemia
title_fullStr Eradication of Pulmonary Aspergillosis in an Adolescent Patient Undergoing Three Allogeneic Stem Cell Transplantations for Acute Lymphoblastic Leukemia
title_full_unstemmed Eradication of Pulmonary Aspergillosis in an Adolescent Patient Undergoing Three Allogeneic Stem Cell Transplantations for Acute Lymphoblastic Leukemia
title_short Eradication of Pulmonary Aspergillosis in an Adolescent Patient Undergoing Three Allogeneic Stem Cell Transplantations for Acute Lymphoblastic Leukemia
title_sort eradication of pulmonary aspergillosis in an adolescent patient undergoing three allogeneic stem cell transplantations for acute lymphoblastic leukemia
url http://dx.doi.org/10.1155/2012/672923
work_keys_str_mv AT michaeladoring eradicationofpulmonaryaspergillosisinanadolescentpatientundergoingthreeallogeneicstemcelltransplantationsforacutelymphoblasticleukemia
AT angelikazierl eradicationofpulmonaryaspergillosisinanadolescentpatientundergoingthreeallogeneicstemcelltransplantationsforacutelymphoblasticleukemia
AT markusmezger eradicationofpulmonaryaspergillosisinanadolescentpatientundergoingthreeallogeneicstemcelltransplantationsforacutelymphoblasticleukemia
AT peterlang eradicationofpulmonaryaspergillosisinanadolescentpatientundergoingthreeallogeneicstemcelltransplantationsforacutelymphoblasticleukemia
AT ruperthandgretinger eradicationofpulmonaryaspergillosisinanadolescentpatientundergoingthreeallogeneicstemcelltransplantationsforacutelymphoblasticleukemia
AT ingomuller eradicationofpulmonaryaspergillosisinanadolescentpatientundergoingthreeallogeneicstemcelltransplantationsforacutelymphoblasticleukemia